Nanomedicine News

RSS

Parabon NanoLabs to Revolutionize Nanotechnology Field

Parabon Computation, a veteran provider of extreme-scale grid computing software and services, announced today the spin-off of Parabon NanoLabs, a subsidiary dedicated to designing and producing breakthrough products at the nano-scale.

From Parabon NanoLabs 31 Mar 2009

Scientists Shed New Light on Possible Way to Starve Cancer Tumors

Scientists have shed new light - literally - on a possible way to starve cancer tumors or prevent side effects from a wide range of drugs. A lock-like molecule designed by University of Florida chemistry researchers c...

30 Mar 2009

Research Allows Identification of Numerous Potential Cancer and Other Treatments

Understanding the tens of thousands of proteins that compose the human proteome has emerged as a key challenge of this century, and research efforts to date have already enabled major advances in drug discovery and understanding basic biology.

30 Mar 2009

New Molecules that have the Power to Identify Targets

Both cancer cells and the chemicals used to make bombs can foil detection because they appear in trace amounts too small for conventional detection techniques. Tel Aviv University has developed the ultimate solution: a m...

30 Mar 2009

Medtech Insight and Windhover Conferences to Host Special International Medical Technology Event

In just 5 short weeks, Medtech Insight and Windhover Conferences will host "Investment In Innovation (In3) Europe," a very special international medical technology investment and partnering event, being held at...

30 Mar 2009

Fluidigm Developing Quantification System Allowing Sequencing of Rare Samples

Fluidigm Corporation today announced a sample quantification system that allows researchers to sequence their libraries of rare samples and also dramatically lower costs, improve data quality and speed up time-to-results for scientists performing next-generation DNA sequencing.

From Standard BioTools 30 Mar 2009

Health Agency Verify Function of CombiMatrix's Influenza-Detection System

CombiMatrix Corporation (Nasdaq:CBMX), a diversified biotechnology business that develops proprietary technologies, including products and services in the areas of drug development, genetic analysis, molecular diagnostics, nanotechnology and defense and homeland security markets, announced today that the Agency for Health Protection and Promotion in Ontario, Canada has, during the 2007-2008 influenza season, verified the function of CombiMatrix's Influenza-Detection system.

From Invitae Corporation 30 Mar 2009

Molecular Assembly Line for Predictable, High-Precision Nano-Construction

Building on the idea of using DNA to link up nanoparticles - particles measuring mere billionths of a meter - scientists at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory have designed a molecular assembly line for predictable, high-precision nano-construction.

29 Mar 2009

Balancing Opportunities and Risks Associated with Nanotechnology

The challenge with all emerging liabilities is to identify risk potentialities at an early stage, and well before they become the subject of court action.

27 Mar 2009

Nanopore Sequencing Slashes Costs of DNA Analysis

Over the past 5 years, researchers have been exploring the use of nanoscale pores as nucleic acid sequencing tools. In theory, such pores should generate a unique response characteristic of each of the four nucleotide ba...

27 Mar 2009